The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the Swiss Chemical Society, Division for Medicinal Chemistry & Chemical Biology (DMCCB) will be organising the International Symposium on Chemical Biology (EFMC-ISCB) on November 16-18, 2023 in Basel, Switzerland.  

Taking over the successful series launched by the NCCR Chemical Biology, the meeting will continue its tradition of high scientific quality and bring together leading scientists to showcase the latest advances in the field of chemical biology. The symposium will be co-chaired by two prominent scientists, one from academia and the other from industry. The symposium programme will include keynote and invited lectures, short communications selected from submitted abstracts, a poster session, and an exhibition - with ample time for discussion and networking.

The programme will include the following sessions:

• Chemical Immunology & Checkpoint Inhibitors
• Chemical Proteomics in Drug Discovery
• Chemically Induced Proximity
• Computational Chemical Biology (LS-EuChemS Session)
• New Understanding of Post-translational Modifications
• Protein Conformations: Beyond the Ground State
• Target Engagement and Mechanism of Action Determination
• Targeting Metabolism (ICBS Session)

For each of the above topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts.

We look forward to welcoming you in Basel!
The Organising Committee

The EFMC | ACSMEDI Medicinal Chemistry Frontiers is co-organised as a collaboration between the EFMC, European Federation for Medicinal chemistry and Chemical biology, and ACS MEDI, the division of Medicinal Chemistry of the American Chemical Society.

The 2024 programme will include:

• 3 high quality plenary lectures
• 9 sessions on key topics in Medicinal Chemistry
• About 18 oral communications selected from the submitted abstracts
• An extensive social programme to maximise your networking opportunities
• A poster session and a commercial exhibition

EFMC | ACSMEDI Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.

Topics

1. New Chemistries for the Preparation of DNA-Encoded Libraries
2. Targeted Protein Degradation
3. Recent Advances in Neurodegenerative Diseases
4. Fragment Based Drug Discovery
5. Protein-protein Interactions
6. Emerging Synthetic Methodologies
7. Targeting Immune Checkpoints with Small Molecules
8. From RNA Targeting to Degraders and Beyond: Impact of Novel Modalities on Clinical Pipelines

Deadlines

Calendar of Abstract Submissions

• Deadline for Oral Communication submission and free Poster submission: January 25, 2024
• Announcement of the accepted oral communications: February 2024
• After January 25 and until February 22, 2024: abstracts for Posters can still be submitted, but with a handling fee of EUR 50,00

Registration Fees

• Early-bird registration deadline: January 25, 2024

We look forward meeting you in Utrecht! 

The Organising Committee

Course Outline:

Technologies for drug discovery are constantly evolving. Significant developments within the last 20 years range from the development of DNA-encoded libraries for hit finding and even hit-to-lead optimisation to the reinvigoration of irreversible inhibitors resulting in innovative oncology drugs such as osimertinib and sotorasib.

This course will cover advanced methods, new technologies and tools available for medicinal chemists, with a focus on oncology drug discovery, including fragment based-drug discovery, DNA-encoded library technologies, covalent drug discovery and small molecules that target RNA. The course will finish with a series of oncology case studies successfully utilising these drug discovery technologies for the development of clinical candidates and marketed drugs.

Course Organisers:

• Prof. Mike Waring (Newcastle University, United Kingdom)
• Dr Hannah Stewart (Newcastle University, United Kingdom)

Local Organiser:

• Prof. Laura Heitman (Leiden University, The Netherlands)

The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 30 member societies and about 9.000 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The most recent EFMC-ISMC meeting took place in France (Nice, 2022).

The 2024 programme will include:

Three parallel sessions with different themes:

1. Chemical Biology
2. Drug Discovery Projects
3. Technologies

In addition, the programme contains five open sessions: First Time Disclosures (I & II), Late Breaking News/Recent Developments, Highlights in Medicinal Chemistry as well as a special session on Early Career Women in Medicinal Chemistry & Chemical Biology. For these sessions, the talks will be selected from the submitted abstracts.

For most of the below topics, two slots in the programme will be available for an oral communication selected out of the submitted abstracts.

Deadlines

Calendar of Abstract Submissions

• Deadline for Oral Communication submission and free Poster submission: March 21, 2024, 24:00 CET
• Announcement of the accepted oral communications: mid May 2024
• After March 21 and until June 20, 2024, abstracts for Posters can still be submitted, but with a handling fee of 50,00€

Registration Fees

• Early-bird registration deadline: March 21, 2024
  Payment of the Early-bird fee is required by April 5, 2024 in order to remain applicable.
• Standard registration deadline: July 2, 2024
• Late registration deadline: September 1, 2024

The 11th edition of the EFMC Young Medicinal Chemists' Symposium will be held in Rome, Italy on September 5-6, 2024 and will be organised by the European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the EFMC Young Scientists Network (YSN). The event will be organised in connection with the XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2024).

Participants will be requested to comply to the COVID-19 safety & health guidelines which will be applicable at the time of the event.

This short symposium has the aim of:

• creating a network of young European investigators
• stimulating young European investigators to share their scientific work with peers and inspiring leaders in the field
• creating competition and excellence within Europe by selecting the European Champion in Medicinal Chemistry and Chemical Biology

The Programme of the 11th EFMC Young Medicinal Chemists’ Symposium will include:

• keynote lectures given by inspiring leaders in the field, with ample time for interaction with the speakers
• oral communications by invited prize winners from national young medicinal chemist meetings in Europe
• flash poster presentations selected from submitted abstracts
• a poster session open to any young researcher submitting an abstract
• an exhibition
• prizes

The scientific programme will also be completed by a series of soft-skill training activities provided to you by the EFMC Young Scientists Network.

We look forward to meet you all!

The EFMC-YMCS Organising Committee

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the Swiss Chemical Society, Division for Medicinal Chemistry & Chemical Biology (DMCCB) will be organising the International Symposium on Chemical Biology (EFMC-ISCB) on January 29-31, 2025 in Basel, Switzerland.  

Taking over the successful series launched by the NCCR Chemical Biology, the meeting will continue its tradition of high scientific quality and bring together leading scientists to showcase the latest advances in the field of chemical biology. The symposium will be co-chaired by two prominent scientists in the field. The programme will include plenary and invited lectures, short communications selected from submitted abstracts, a poster session, and a commercial exhibition - with ample time for discussion and networking.